[SciNova Investment Positioning]
SciNova Investment drives life sciences, with clinical medical research as the foundation, equity investment as the means, and medical transformation centers as the assistance, to promote the upgrading of China's medical industry and create a leader in driving global life sciences.
[Establishment and Vision of Chuanrui Investment]
Founded in 2009, Shanghai SciNova is an investment company that manages both equity investment funds and medical science and technology achievements transformation platforms. With promoting the upgrading of China's medical industry as its core value, it is committed to investing in high-end medical science and technology innovation in China and the world.
2009-2014 Successfully transformed over 30 advanced medical technologies into China
2015-2016 Construction of 4 conversion centers , including cooperation with Cleveland Hospital in the United States
2017-2022 Collaborating with four domestic and foreign medical universities to build a medical industry fund
[Scale of SciNova Investment Fund]
SciNova has invested more than 3 billion yuan in nearly 40 international and domestic enterprises.As of December 2022, 7 invested enterprises have successfully listed and 7 companies are waiting for the IPO.
[SciNova Investment Achievement Transformation Platform]
SciNova has formed alliances with famous medical universities at home and abroad, such as Cleveland Hospital in the United States, Stanford Hospital in the United States, Maccabi Hospital in Israel, Chongqing Medical University, Chengdu University of Traditional Chinese Medicine, to jointly build an official platform for the transformation of scientific and technological achievements.
[SciNova Investment Industry Partner]
SciNova cooperates with several powerful industrial groups, including Chongqing Chemical and Medical Group, Chongqing Dianshi Chuangjian (a subsidiary of Chongqing Xintian Investment), Hangshi Group, Huai'an Water Resources Group, Hongkun Group and other well-known enterprises.